Log In
Print this Print this

ImOI100 (RGT100)

  Manage Alerts
Collapse Summary General Information
Company Rigontec GmbH
DescriptionSynthetic dsRNA RIG-I agonist
Molecular Target DEAD box polypeptide 58 (RIG-I) (DDX58)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today